AXM Pharma (AXMP) Stock Statistics & Valuation Metrics
Total Valuation
AXM Pharma has a market cap or net worth of $40.86K. The enterprise value is ―.
- Market Cap
- $40.86K
- Enterprise Value
- ―
Share Statistics
AXM Pharma has 408,603,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 408,603,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Income Statement
In the last 12 months, AXM Pharma had revenue of ― and earned -148.67K in profits. Earnings per share was ―.
- Revenue
- ―
- Gross Profit
- 1,792
- Operating Income
- -148.75K
- Pretax Income
- ―
- Net Income
- -148.67K
- EBITDA
- -143.72K
- Earnings Per Share (EPS)
- ―
Stock Price Statistics
- Beta
- 56.79
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.10
- 200-Day Moving Average
- 0.10
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Balance Sheet
AXM Pharma has ― in cash and marketable securities with $3.65M in debt, giving a net cash position of ― billion.
- Cash & Marketable Securities
- ―
- Total Debt
- $3.65M
- Net Cash
- ―
- Net Cash Per Share
- ―
- Tangible Book Value Per Share
- ―
Analyst Forecast
The average price target for AXM Pharma is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
